PTSD Treatment in Maplewood, NJ

Several DSM-5-TR specifiers sit under PTSD. The dissociative subtype — marked by prominent depersonalization (feeling detached from your body or thoughts) or derealization (feeling the world is unreal or dreamlike) — appears in roughly 15–30% of PTSD cases, tends to be more severe, and prompts slower pacing during trauma-focused therapy. Delayed-expression PTSD means full criteria aren’t met until at least six months after the event. PTSD in children 6 and youngeruses modified criteria; we don’t see children under 12.

Complex PTSD (C-PTSD) is recognized in the ICD-11 as a separate diagnosis from PTSD. It typically follows chronic, repeated, or developmentally early trauma — childhood abuse, prolonged domestic violence, trafficking, sustained combat, captivity — and includes not only the core PTSD symptoms but also persistent disturbances in self-organization: severe difficulty regulating emotions, a pervasive negative self-concept (feeling worthless, broken, permanently damaged), and profound difficulty sustaining close relationships. ICD-11 specifies that a person receives either PTSD or C-PTSD, not both. Clinically, C-PTSD usually requires a longer treatment arc than classic PTSD, often blending trauma-focused work with skills-based interventions for emotion regulation and relational repair.

Acute stress disorderis distinct: the same symptom picture as PTSD but during the first month after trauma. About half of people with acute stress disorder progress to PTSD without intervention; the other half recover through natural processing. We assess which trajectory you’re on and focus early intervention on psychoeducation, safety, sleep, and avoiding iatrogenic harm — not on premature trauma-focused work.

The strongest evidence in all of PTSD treatment sits with three trauma-focused psychotherapies. The APA 2025 guideline, the VA/DoD 2023 guideline, and the ISTSS 3rd-edition guidelines all converge on this: trauma-focused psychotherapy is the gold standard, and it should be offered to most patients as the primary intervention, with medication as a complement rather than a replacement.

Cognitive Processing Therapy (CPT)is a structured 12-session protocol that helps you identify and revise “stuck points” — beliefs about the trauma that keep you stuck in guilt, shame, or self-blame. CPT is highly manualized, works well for adults across trauma types, and is particularly effective for patients whose PTSD is anchored in negative cognition as much as in fear.

Prolonged Exposure (PE) is roughly 8–15 weekly 60–90-minute sessions that build the skill of approaching — rather than avoiding — trauma memories and reminders, in imagination and in vivo. PE has perhaps the largest effect sizes in all of PTSD treatment and works well for patients whose PTSD is anchored in fear and avoidance. It is more demanding than CPT on a week-to-week basis; the payoff is substantial and durable.

Eye Movement Desensitization and Reprocessing (EMDR) is a 6–12-session protocol that pairs attention to the trauma memory with bilateral stimulation (usually guided eye movements) to facilitate reprocessing. EMDR is as effective as CPT and PE for many patients, requires less daily homework, and is a good fit for patients who find prolonged verbal exposure overwhelming.

Teresa is your prescribing clinician; CPT, PE, and EMDR are delivered by specialized therapists. We coordinate referrals with NJ-licensed trauma-focused therapists who have current openings, we share records with your consent, and we stay in close contact as your therapy progresses so medication and therapy move in the same direction rather than pulling against each other.

Trauma-focused psychotherapy delivered by telehealth can be clinically appropriate for many patients, including those receiving PE, CPT, and EMDR protocols from a therapist trained in those modalities. For many PTSD patients — those with agoraphobia-like avoidance, patients in rural or transit-limited parts of New Jersey, parents of young children who can’t consistently leave home, and survivors for whom the physical act of traveling to an office is itself a trigger — telehealth is not the fallback. It is what makes treatment accessible at all.

We cover privacy practicalities together at the first visit: headphones, a private room when possible, the plan if someone walks in, and what to do if the connection drops mid-session. Teresa’s medication management is delivered via telehealth when clinically appropriate; controlled-substance prescribing follows current DEA rules and applicable New Jersey requirements.

Prazosin is an alpha-1 adrenergic antagonist originally developed for hypertension and now widely used off-label for trauma-related nightmares and sleep disruption in PTSD. The evidence base is mixed — some large trials have been neutral — but clinical experience and the VA/DoD guideline support its use, particularly when nightmares are a primary driver of sleep deprivation and functional impairment. Mechanistically, prazosin blunts the noradrenergic surge during REM sleep that appears to drive trauma nightmares.

We start at 1 mg at bedtime and titrate every 5–7 days to a typical target of 4–8 mg, with some patients benefiting up to 12–16 mg. Orthostatic hypotension is the main side effect to watch; we check blood pressure at baseline and after each dose change, advise you to rise slowly from lying or sitting, and hold the dose if dizziness or near-faints occur. Prazosin is not addictive, does not interact meaningfully with most psychiatric medications, and tends to produce benefit within 1–2 weeks of reaching an effective dose — faster than SSRI onset, which makes it a useful early win in a treatment plan where symptom relief can otherwise feel slow.

Complex PTSD responds to the same first-line therapies — CPT, PE, EMDR — but often requires more sessions, more pacing, and a longer treatment arc. We coordinate with therapists experienced in C-PTSD, which often means blending the trauma-focused protocol with emotion-regulation skills (drawn from DBT), interpersonal-effectiveness work, and somatic or body-based components for patients for whom purely cognitive approaches don’t access the stored physiological material.

When an adequate SSRI or venlafaxine trial (10–12 weeks at a therapeutic dose) hasn’t produced sufficient benefit, several augmentation strategies have evidence, though the evidence base is thinner than for first-line monotherapy. Mirtazapine (15–45 mg at bedtime) can augment sleep and appetite and has mild anxiolytic effect. Low-dose atypical antipsychotics (quetiapine, risperidone) have modest evidence for PTSD augmentation but warrant metabolic monitoring and are not first-line monotherapy. For treatment-resistant PTSD not responding to two or more adequate medication trials plus trauma-focused therapy, we refer to New Jersey-based programs offering interventional options. MDMA-assisted therapy remains investigational; ketamine and stellate ganglion block for PTSD specifically have insufficient evidence for routine use per the VA/DoD guideline.

PTSD is associated with elevated suicide risk, particularly during acute symptom flares, after major stressors, and during periods of intensified avoidance. We build explicit safety planning into early care: identifying personal warning signs, naming trusted contacts, addressing access to means during high-risk periods, and establishing an escalation pathway. Columbia Suicide Severity Rating Scale (C-SSRS) screening is part of initial evaluation and is repeated when the clinical picture shifts.

If you are in crisis right now: call or text 988 (Suicide & Crisis Lifeline) any time, day or night — free, confidential, staffed by trained counselors. If you are in immediate physical danger or unable to keep yourself safe, call 911 or go to the nearest emergency room. In New Jersey, NJ Hopeline (1-855-654-6735) is a state-specific option, and each county has a Psychiatric Emergency Screening Service (PESS) for in-person mobile crisis response. Our clinic is not a 24/7 crisis service; we follow up at the next scheduled visit after any crisis contact and adjust the plan to reduce future risk.

For in-the-moment trigger response, a few grounding techniques reliably shorten a flashback or dissociative episode: the 5-4-3-2-1 sensory scan (name 5 things you see, 4 you can touch, 3 you hear, 2 you smell, 1 you taste), slow paced breathing with long exhales (which activates the parasympathetic brake), cold water on the face or ice held in the hand (the mammalian dive reflex), and orienting to the current date, location, and present safety. We practice these during sessions rather than handing you a list and hoping you remember them in the moment.

Trauma-informed care is a set of practices, not a marketing phrase. In this practice it means: explicit consent for every step of the interview, permission for you to pause or skip any question, pacing that respects your nervous system, predictability and transparency about what happens next, a clear collaborative plan for medication changes, attention to cues of dissociation or overwhelm in the visit itself, and the assumption that the behaviors that brought you here — avoidance, hypervigilance, shutdown — are adaptive responses to what happened, not character flaws to be corrected.

Teresa is a PMHNP-BC — a board-certified Psychiatric Mental Health Nurse Practitioner — with 5 years of clinical experience across conditions including PTSD and complex trauma. Her role is diagnosis, medication management, brief supportive therapy integrated into visits, and coordination with trauma-focused therapy specialists. For structured CPT, PE, or EMDR, we refer to NJ-licensed specialists with openings; we stay in active contact with your therapist throughout treatment. PT patients rarely benefit from fragmented care; the coordinated model is what works.

Hybrid telehealth and in-person care is what most patients end up with. The initial evaluation is often in-person when logistics permit, though telehealth works well when they don’t. Routine medication management, rapid contact during symptom flares, and continuity during life disruptions are well-suited to telehealth. For patients managing agoraphobia-like avoidance, telehealth remains appropriate long-term.